Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK aspirin warning

This article was originally published in The Tan Sheet

Executive Summary

Label statement warning parents not to give aspirin to children under 12 without the advice of a doctor should be extended to children under 16 to further reduce risk of Reye's Syndrome, Medicines Control Agency proposes in Oct. 22 1consultation letter. Committee on Safety of Medicines advised MCA that while Reye's Syndrome in children up to 11 years old "has almost disappeared...cases have continued to occur in children over 12." Current warning stating "avoid up to and including 15 years of age if feverish" is "too complex," should be simplified to "do not give to children aged under 16," letter states. Comments will be accepted until Dec. 31; new warnings could take effect by March 2003...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094743

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel